As the regulatory landscape around the governance of artificial intelligence, health data reuse and innovation continues to evolve, our research and innovation community find themselves navigating a transition from one set of known governance expectations to additional challenges.
MedTech companies can offer benefits to multiple stakeholders within the healthcare ecosystem. Especially when it comes to the use and reuse of health data. But to unlock all this potential, we need to ensure that the data is of high quality.
Today is a day that i~HD reflects on solemnly and with hope because Data Protection and Privacy are core to our founding principles and our work. We lead on several EU projects for data protection and ethics, we have developed codes of practice for the safe and effective use of data, we have co-run roundtables exploring the impact of novel innovation approaches including Artificial Intelligence, and we have developed educational, outreach and quality assessments for Information Governance, ethics and their role in data driven innovation.
In any healthcare organization it is critical that the importance of data quality be properly explained. From management perspective to the healthcare providers, a sensible and understandable rationale must be given in order to obtain active participation in the data quality effort.
By Nathan Lea, i~HD DPO & Information Governance Lead For over three years handling of EU Citizen’s personal data has been governed by the General Data Protection Regulation but my involvement with anticipating its impacts predated this. There were points in 2017 where I sensed something special was about to happen – in my discussions with colleagues and reviews of the agreed […]
The European Commission has, since the introduction of the General Data Protection Regulation (GDPR), made efforts towards the implementation of policies and regulations which are fit for the digital age while also ensuring trustworthy and safe use and reuse of data.
By Dipak Kalra, President i~HD There is a growing momentum right across Europe to scale up our learning from routinely collected health data (real-world data – RWD). The need for us to learn more from data is widely recognised by all stakeholders. We need to track health outcomes so that we can optimise our care pathways to deliver the best possible […]
By Geert Thienpont, Managing Director i~HD is pleased to observe the growth of the potential that mobile health apps are offering. We can see that the necessary caution is being taking by the ICT industry and it is great that governments and NGOs are taking measures to safeguard the quality of mobile health apps and the safety of the citizen.   A few examples:    the validation pyramid initiative of mHealthBelgium is an initiative of the Belgian Federal […]
Health data are often re-used to improve patient outcomes and to foster innovation. To allow valid and reliable decision making based on health data, it is of utmost importance to ensure the data are of high quality. In this blog article, we describe our take on what constitutes data quality, where to put the threshold for data to be considered of high quality, and how we have formalised this into an assessment framework.
i~HD